NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 215 filers reported holding NOVAVAX INC in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $77,106 | -10.2% | 10,650 | -7.9% | 0.00% | – |
Q2 2023 | $85,891 | +74.8% | 11,560 | +63.0% | 0.00% | – |
Q1 2023 | $49,148 | -1.7% | 7,092 | +45.8% | 0.00% | – |
Q4 2022 | $49,991 | -23.1% | 4,863 | +36.4% | 0.00% | – |
Q3 2022 | $65,000 | -58.6% | 3,565 | +16.5% | 0.00% | – |
Q2 2022 | $157,000 | -96.6% | 3,059 | -95.2% | 0.00% | – |
Q1 2022 | $4,674,000 | -83.5% | 63,469 | -68.0% | 0.00% | -100.0% |
Q4 2021 | $28,363,000 | -90.6% | 198,245 | -86.4% | 0.00% | -91.7% |
Q3 2021 | $303,068,000 | -70.8% | 1,461,909 | -70.1% | 0.02% | -70.4% |
Q2 2021 | $1,037,178,000 | +19.4% | 4,885,203 | +2.0% | 0.08% | +9.5% |
Q1 2021 | $868,639,000 | +345.0% | 4,790,910 | +173.7% | 0.07% | +335.3% |
Q4 2020 | $195,210,000 | +67.5% | 1,750,608 | +62.7% | 0.02% | +41.7% |
Q3 2020 | $116,577,000 | +75599.4% | 1,075,933 | +58121.5% | 0.01% | – |
Q2 2020 | $154,000 | – | 1,848 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 50,910 | $5,516,000 | 10.50% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 297,400 | $32,223,000 | 4.94% |
Ikarian Capital, LLC | 375,400 | $40,675,000 | 2.94% |
TSP Capital Management Group, LLC | 60,075 | $6,509,000 | 2.66% |
RA Capital Management | 1,198,602 | $129,869,000 | 2.38% |
Foresite Capital Management I, LLC | 66,810 | $7,239,000 | 2.04% |
Healthcare Value Capital, LLC | 5,000 | $542,000 | 1.79% |
Rock Springs Capital Management LP | 585,705 | $63,461,000 | 1.61% |
Foresite Capital Management II, LLC | 67,373 | $7,300,000 | 1.59% |
BERYLSON CAPITAL PARTNERS, LLC | 30,104 | $3,262,000 | 1.14% |